Catalent (CTLT)
(Delayed Data from NYSE)
$60.00 USD
-0.11 (-0.18%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $59.97 -0.03 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
CTLT 60.00 -0.11(-0.18%)
Will CTLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CTLT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CTLT
Do Options Traders Know Something About Catalent (CTLT) Stock We Don't?
Catalent (CTLT) Upgraded to Strong Buy: Here's What You Should Know
CTLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up
Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates
JAZZ or CTLT: Which Is the Better Value Stock Right Now?
Other News for CTLT
UBS highlights 30 stocks poised for potential moves after the Fed’s expected rate cut
J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report
Decoding Catalent Inc (CTLT): A Strategic SWOT Insight
Catalent delays 10-K filing
Catalent reports Q4 adjusted EPS 65c, consensus 47c